EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.5.1.16 | Leukemia |
3162218 |
2-Mercaptoethylamine, a competitive inhibitor of spermidine synthase in mammalian cells. |
ongoing research therapeutic application unassigned |
2 1 0 |
2.5.1.16 | Leishmaniasis |
22684087 |
A leishmaniasis study: Structure-based screening and molecular dynamics mechanistic analysis for discovering potent inhibitors of spermidine synthase. |
therapeutic application unassigned |
4 0 |
2.5.1.16 | Chagas Disease |
26881725 |
An NMR Biochemical Assay for Fragment-Based Drug Discovery: Evaluation of an Inhibitor Activity on Spermidine Synthase of Trypanosoma cruzi. |
causal interaction unassigned |
2 0 |
2.5.1.16 | Leukemia |
7116328 |
Antitumor effect of dicyclohexylammonium sulfate, a potent inhibitor of spermidine synthase against P388 leukemia. |
ongoing research therapeutic application unassigned |
3 4 0 |
2.5.1.16 | Carcinoma |
7332714 |
Antitumor effect of dicyclohexylammonium sulfate, a potent inhibitor of spermidine, synthase. |
ongoing research therapeutic application unassigned |
2 1 0 |
2.5.1.16 | Cysts |
19965964 |
Arabidopsis spermidine synthase is targeted by an effector protein of the cyst nematode Heterodera schachtii. |
therapeutic application unassigned |
1 0 |
2.5.1.16 | Nematode Infections |
19965964 |
Arabidopsis spermidine synthase is targeted by an effector protein of the cyst nematode Heterodera schachtii. |
therapeutic application unassigned |
1 0 |
2.5.1.16 | Infections |
27795357 |
Arginase Is Essential for Survival of Leishmania donovani Promastigotes but Not Intracellular Amastigotes. |
ongoing research therapeutic application unassigned |
3 1 0 |
2.5.1.16 | Malaria |
27661085 |
Binding and Inhibition of Spermidine Synthase from Plasmodium falciparum and Implications for In Vitro Inhibitor Testing. |
therapeutic application unassigned |
4 0 |
2.5.1.16 | Neoplasms |
27661085 |
Binding and Inhibition of Spermidine Synthase from Plasmodium falciparum and Implications for In Vitro Inhibitor Testing. |
therapeutic application unassigned |
4 0 |